RWR 4 FILLIES OILY ANABOLIC INJECTION FOR FILLIES AND MARES

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:

METHANDRIOL DIPROPIONATE; NANDROLONE PHENYLPROPIONATE

Available from:

RWR VETERINARY PRODUCTS PTY LTD

INN (International Name):

methandriol dipropionate(45mg/mL) + others

Pharmaceutical form:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composition:

METHANDRIOL DIPROPIONATE STEROID-ANABOLIC Active 45.0 mg/ml; NANDROLONE PHENYLPROPIONATE STEROID-ANABOLIC Active 30.0 mg/ml

Units in package:

10mL

Class:

VM - Veterinary Medicine

Manufactured by:

RWR VETERINARY PRODS

Therapeutic group:

HORSE FILLY (YOUNG FEMALE) | HORSE MARE (FEMALE) | FEMALE HORSE | HORSE - YOUNG FEMALE

Therapeutic area:

ENDOCRINE SYSTEM

Therapeutic indications:

ANABOLIC STEROID | ABORTION THREAT | ANDROGENIC PROPERTIES | BONE REPAIR | CATABOLIC COMPLICATIONS | CONVALESCENCE | ERYTHROPOIETIC ACTIVITY | GERIATRIC THERAPY | IMPROVE APPETITE | MALE SEXUAL CHARACTERISITICS | MUSCLE DEVELOPMENT | NON-VIRILISING ANABOLIC | PATHOPHYSIOLOGICAL PROCESS | PROTEIN AND MINERAL ANABOLIC | SKELETAL CONDITIONS | TISSUE BREAKDOWN | TISSUE REPAIR | VIRILISING ANABOLIC

Product summary:

Poison schedule: 4; Withholding period: WHP: MEAT WITHHILDING PERIOD: NOT TO BE USED in horses that may be slaughtered for human consumption.; Host/pest details: HORSE FILLY (YOUNG FEMALE): [ANABOLIC STEROID]; HORSE MARE (FEMALE): [ANABOLIC STEROID]; Anabolic steroid with low androgenic effect for horses.NOT TO BE USED I horses that will be slaughtered for human consumption.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

                                10mL
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
OILY ANABOLIC INJECTION
FOR FILLIES AND MARES
ACTIVE CONSTITUENTS:
METHANDRIOL DIPROPIONATE 45mg/mL
NANDROLONE PHENYLPROPIONATE 30mg/mL
4 FILLIES
RWR
ANABOLIC STEROID WITH LOW
ANDROGENIC EFFECT FOR HORSES.
10mL
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
OILY ANABOLIC INJECTION
FOR FILLIES AND MARES
ACTIVE CONSTITUENTS:
METHANDRIOL DIPROPIONATE 45mg/mL
NANDROLONE PHENYLPROPIONATE 30mg/mL
4 FILLIES
RWR
ANABOLIC STEROID WITH LOW
ANDROGENIC EFFECT FOR HORSES.
4 FILLIES
RWR
OILY ANABOLIC INJECTION
FOR FILLIES AND MARES
DIRECTIONS FOR USE:
Unused portion should be
discarded 24 hours after first
broaching vial. Administer by
intramuscular injection only.
ADULT HORSES: 5mL
WEANLINGS: 3mL
FOALS: 2mL
Every 2 weeks or as directed
by a veterinary surgeon.
IF USED IN PERFORMANCE
ANIMALS, THE REGULATIONS OF
THE RELEVANT AUTHORITIES
REGARDING MEDICATION
SHOULD BE OBSERVED.
MEAT WITHHOLDING
PERIOD: NOT TO BE USED
IN HORSES THAT MAY BE
SLAUGHTERED FOR HUMAN
CONSUMPTION.
FIRST AID:
If poisoning occurs, contact
a doctor or Poisons
Information Centre.
_Phone: Australia 131126._
DISPOSE of empty container
by wrapping with paper and
putting in garbage.
STORE below 25ºC (Air
Conditioning). Protect from
light.
APVMA No.: 59360/10ML/0508
B: Exp:
DOM:
RWR VETERINARY PRODUCTS PTY LTD
Suite 601, 7 Help St.
Chatswood NSW 2067
DIELINE
PMS 248 [Colour to be
confirmed]
BLACK
9 322387 001441
Alter Existing Art 29/05/07
Add spec text 25/08/08
ALT ART 03/12/08
ALT ART 04/12/08
w/t: 00000
date: 04/12/08
artist: ALFRED
c l
i
e n t
u s e
date
ok
size: 142.75x162.5mm
file name: 4 Fillies 10ml CTN
LABELCRAFT
phone 9550 0999
fax 9550 9734
notes
p l e a s e p r o o f a r t c a r e f u l l y , a n y e r r o r s
o v e r l o o k e d b e c o m e s t h e c l i e n t ’ s l i a b i l
i t y
FILE NAME: 59360_41701_10ML_PRIMARY_MPL_V01.PDF
DIMENSIONS: 142.75MM X 162.5MM
SCALE: 100% WHEN PRINTED TO A4
(96% IF FIT TO PAGE)
100% WHEN PRIN
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                Page
1
of 4
MATERIAL SAFETY DATA SHEET
_RWR4 FILLIES OILY INJECTION_
STATEMENT OF HAZARDOUS NATURE:
Hazardous according to criteria of Worksafe Australia.
COMPANY DETAILS
COMPANY:
RWR PRODUCTS Pty Limited
ADDRESS:
SUITE 601, 7 Help St
Chatswood
NSW 2067
TELEPHONE NUMBER:
+61 (02) 49616422
EMERGENCY TELEPHONE NUMBER:
+61 (02) 49616422 (Business Hours)
Poisons Information Service: 131126
FACSIMILE NUMBER:
+61 (02) 49616433
IDENTIFICATION
PRODUCT NAME:
_RWR 4 Fillies Oily Injection _
OTHER NAMES:
_RWR 4 Fillies _
MANUFACTURER’S PRODUCT CODE:
4 Fil
UN NUMBER:
None allocated
DANGEROUS GOODS CLASS AND SUBSIDIARY RISK:
None allocated
HAZCHEM CODE:
None allocated
POISONS SCHEDULE NUMBER:
Schedule 4
USE:
An anabolic steroid with low androgenic effect for horses. For animal
treatment only.
Page
2
of 4
MATERIAL SAFETY DATA SHEET
_RWR4 FILLIES OILY INJECTION_
PHYSICAL DESCRIPTION/PROPERTIES:
APPEARANCE:
Clear pale yellow oily solution, contained in a 10 mL labelled amber
glass vial sealed with a rubber
stopper and aluminium cap, packaged in a labelled outer carton.
PH:
Not applicable
BOILING POINT/MELTING POINT:
Not determined
VAPOUR PRESSURE:
Not determined
SPECIFIC GRAVITY:
Not determined
FLASHPOINT:
Not determined
FLAMMABILITY LIMITS:
Not determined
SOLUBILITY IN WATER:
Miscible in water
OTHER PROPERTIES:
No other information
INGREDIENTS:
CHEMICAL NAME
CAS NUMBER
PROPORTION
*
Methandriol Dipropionate
521-10-8 (Methandriol)
4.5% (45 mg/mL)
*
Nandrolone Phenylpropionate
62-90-8
3% (30 mg/mL)
Benzyl Benzoate
120-51-4
10%
Benzyl Alcohol
100-51-6
10%
Ingredients determined not to be hazardous
to 100%
HEALTH HAZARD INFORMATION
HEALTH EFFECTS:_ _
_ _
_ACUTE: _
Anabolic steroids give rise to side effects related to their
androgenic or anabolic effects. High doses of
androgens may cause altered liver function with jaundice, fluid
retention, high blood cholesterol, and
occasionally enhanced red blood cell production. Androgens also may
cause masculinization in
women and gynecomastia (breast development) in men.
SWALLOWED:
Health 
                                
                                Read the complete document